Ionis Pharmaceuticals (IONS)
(Delayed Data from NSDQ)
$41.83 USD
-0.93 (-2.17%)
Updated Sep 23, 2024 03:59 PM ET
After-Market: $41.84 +0.01 (0.02%) 5:26 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
IONS 41.83 -0.93(-2.17%)
Will IONS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IONS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IONS
Ionis Stock Drops 12% on Pricing of $500M Common Stock Offering
Why Is Zoetis (ZTS) Up 1.4% Since Last Earnings Report?
IONS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biogen's Phase II/III SMA Study for Higher Spinraza Dose Meets Goals
Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue?
How Should You Play AstraZeneca (AZN) After Q2 Beat, View Raise?
Other News for IONS
January 2027 Options Now Available For Ionis Pharmaceuticals (IONS)
Stock moves reflect downgrade for US economic growth outlook - Goldman
January 2026 Options Now Available For Ionis Pharmaceuticals
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today